HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal ... (HealthSouth HealthSouth is the nation...)

(Date:5/12/2008)...ON, May 13 /PRNewswire/ -- Chiltern, a leading glo...pened a new office in Lisbon,Portugal. Mr. Ricard...Manager. Mr. Diaz has over 10 years experience in ...harmacology, a Master,s in Clinical trials and,an ... clinical research,professionals, supporting Chilt...

(Date:5/12/2008)...itish researchers who pioneered treatments which h...ritis and other autoimmune diseases have been awar...r Biomedical Research, announced today. , Emerit... Feldmann, who have been carrying out research tog...were selected for the $100K award by an internatio...

(Date:5/12/2008)...ct proceeds despite non-compliance with California...t (CEQA)., LOS ANGELES, May 12 /PRNewswire-USNews...MC) today went ahead with the planned expansion of...urt Judge Thomas I. McKnew,Jr. has upheld charges...d.,The groundbreaking ceremony held today appears ...

(Date:5/12/2008)... First approved dental anesthetic reversal ag...armaceuticals, Inc., a,dental specialty pharmaceut...es Food and Drug Administration (FDA) has granted ...mesylate). OraVerse is the first,pharmaceutical ag...thesia,and the associated functional deficits resu...

Breaking Medicine News(10 mins):Health News:Chiltern Announces New Expansion in Portugal 2 Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 2 Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 3 Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 4 Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2 Health News:Novalar Receives FDA Approval for OraVerse(TM) 2 Health News:Novalar Receives FDA Approval for OraVerse(TM) 3

[0] Chiltern Announces New Expansion in Portugal [0] Researchers who helped millions with arthritis receive prestigious Janssen Award [0] Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility [0] Novalar Receives FDA Approval for OraVerse(TM)

...ion predicts whether children with ADHD (Attention...uct problems such as lying, fighting, bullying and..., published in the January 2007 issue of the Ameri...l, Developmental Psychology, also found that early...

...reated a unique way of identifying patients at ris... // Professor Paul F. van der Stelt and his team a...loped the largely automated approach during a thre...tion with the Universities of Manchester, Athens, ...

...heart attack is tough enough without facing depres...lf of heart attack survivors. //Depression after a...tion. Different variations have different effects ...e issue of the Harvard Heart Letter. People with ...

... mature physically sooner than their peers and who... older have a higher risk for substance abuse, sex...to a study. “Adolescent girls and boys all are at...hol and drugs,” said Carolyn Tucker Halpern, assoc...

Other Medicine News:Health News:For ADHD Children, Mother’s Depression, Predict Conduct Problem 2 Health News:Osteoporosis to Be Detected During Routine Dental X-rays 2 Health News:Girls With Early Puberty at Greater Risk for Drugs, Sex, Alcohol 2

For ADHD Children, Mother’s Depression, Predict Conduct Problem Osteoporosis to Be Detected During Routine Dental X-rays Variations of Post–Heart Attack Depression Affect Recover Girls With Early Puberty at Greater Risk for Drugs, Sex, Alcohol

(Date:5/9/2008)...OK, Thailand, May 9 /PRNewswire-USNewswire/ -- An ...or the Protection of Animals (WSPA),is on stand-by...truck,Myanmar to assess and then relieve the suffe...depend on for food and their livelihoods., WSPA...culture,Organization of the United Nations (FAO) w...

(Date:5/9/2008)..., Fla., May 9 /PRNewswire-USNewswire/ -- Many stro...fects. These can include nausea and,vomiting with ...nic use.,Such symptoms can lead patients to discon...o pain management for physicians. The novel invest...g oral analgesic, provided pain,relief for patient...

(Date:5/9/2008)...LE, May 9 /PRNewswire-USNewswire/ -- The risk of t...prostatic hyperplasia (BPH), can be,reduced by cha...aining a,normal weight and eating a healthy diet. ...r Prevention Program at Fred Hutchinson Cancer Res...s that suggest men need not,feel helpless against ...

(Date:5/9/2008)... Cytopia,s development of early pipeline cancer dr...swire-FirstCall/ -- Cytopia Limited,(ASX: CYT) tod...er drug,discovery and development collaboration wi... leverages Cytopia,s early stage drug discovery pi...herapeutics that is one of the,fastest growing seg...

Breaking Medicine Technology:Animals That Cyclone Survivors Depend on Need Help Now 2 New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2 New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3 New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4 Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2 Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3 Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4 Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 2 Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 3 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 1 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 2 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 3 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 4 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 5 Cell Genesys Reports Fourth Quarter and Year End 2007 Results 13069 6 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 1 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 2 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 3 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 4 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 5 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 6 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 7 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 8 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 9 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 10 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 11 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 12 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 13 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 14 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 15 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 16 Cardiac Science Reports Record Fourth Quarter and Full Year 2007 Results 13067 17 Dr Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 13065 1 Dr Robert Leonard First in New England to Offer Genetic Test for Male Pattern Baldness 13065 2 Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF 3B Appeal Still Planned Against Narrowed Claims 13063 1 Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF 3B Appeal Still Planned Against Narrowed Claims 13063 2

[0] Animals That Cyclone Survivors Depend on Need Help Now [0] New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR [1] Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15)[0] Cytopia Announces Novel Anti-Cancer Drug Development Collaboration

...ents treated with VELCADE, cyclophosphamide,and p...8, 2007 /PRNewswire-FirstCall/ -- Millennium,Pharm...n of results,from clinical trials of VELCADE based...omplete response(1) (CR) rates in previously,treat...were,presented at the prestigious 11th Internation...

...gis Decreases Incidence of Recurrent Wheeze by,Alm... June 29, 2007,/PRNewswire-FirstCall/ -- Abbott an..., published in the July issue of Journal of,Pediat...vizumab),may reduce recurrent wheezing in prematur...y showed that premature infants without,chronic lu...

Other Medicine Technology:Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5

Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants

...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...

Medicine Products:

CEA Cd, Blood CBC with Platelet Count & Automated Differential Cathepsin D, Paraffin

HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal ...(HealthSouth HealthSouth is the nation...),Health